218 related articles for article (PubMed ID: 25981945)
1. Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability.
Giorgetti R; Marcotulli D; Tagliabracci A; Schifano F
Forensic Sci Int; 2015 Jul; 252():127-42. PubMed ID: 25981945
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
Lofwall MR; Griffiths RR; Mintzer MZ
Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
[TBL] [Abstract][Full Text] [Related]
3. [Psychedelic effects of subanesthetic doses of ketamine].
Zou L; Tian SY; Quan X; Ye TH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):68-72. PubMed ID: 19317064
[TBL] [Abstract][Full Text] [Related]
4. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.
Carter LP; Kleykamp BA; Griffiths RR; Mintzer MZ
Psychopharmacology (Berl); 2013 Mar; 226(1):53-63. PubMed ID: 23096769
[TBL] [Abstract][Full Text] [Related]
5. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later.
Curran HV; Morgan C
Addiction; 2000 Apr; 95(4):575-90. PubMed ID: 10829333
[TBL] [Abstract][Full Text] [Related]
6. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
Morgan CJ; Muetzelfeldt L; Curran HV
Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
[TBL] [Abstract][Full Text] [Related]
7. Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes.
Suzuki M; Tsueda K; Lansing PS; Tolan MM; Fuhrman TM; Sheppard RA; Hurst HE; Lippmann SB
Can J Anaesth; 2000 Sep; 47(9):866-74. PubMed ID: 10989856
[TBL] [Abstract][Full Text] [Related]
8. Recent trends in the use of "club drugs": an Australian review.
Degenhardt L; Copeland J; Dillon P
Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
[TBL] [Abstract][Full Text] [Related]
9. Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later.
Uhlhaas PJ; Millard I; Muetzelfeldt L; Curran HV; Morgan CJ
J Psychopharmacol; 2007 May; 21(3):347-52. PubMed ID: 17591661
[TBL] [Abstract][Full Text] [Related]
10. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
Morgan CJ; Muetzelfeldt L; Curran HV
Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
[TBL] [Abstract][Full Text] [Related]
11. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory.
Pitsikas N; Boultadakis A; Sakellaridis N
Neuroscience; 2008 Jun; 154(2):454-60. PubMed ID: 18472348
[TBL] [Abstract][Full Text] [Related]
12. [Ketamine--dreams and realities].
Arditti J; Spadari M; de Haro L; Brun A; Bourdon JH; Valli M
Acta Clin Belg; 2002; 57 Suppl 1():31-3. PubMed ID: 11974440
[TBL] [Abstract][Full Text] [Related]
13. Ketamine use: a review.
Morgan CJ; Curran HV;
Addiction; 2012 Jan; 107(1):27-38. PubMed ID: 21777321
[TBL] [Abstract][Full Text] [Related]
14. A review of the nonmedical use of ketamine: use, users and consequences.
Jansen KL
J Psychoactive Drugs; 2000; 32(4):419-33. PubMed ID: 11210204
[TBL] [Abstract][Full Text] [Related]
15. Paliperidone for the treatment of ketamine-induced psychosis: a case report.
Zuccoli ML; Muscella A; Fucile C; Carrozzino R; Mattioli F; Martelli A; Orengo S
Int J Psychiatry Med; 2014; 48(2):103-8. PubMed ID: 25377151
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairments in poly-drug ketamine users.
Liang HJ; Lau CG; Tang A; Chan F; Ungvari GS; Tang WK
Addict Behav; 2013 Nov; 38(11):2661-6. PubMed ID: 23899429
[TBL] [Abstract][Full Text] [Related]
17. [New drugs at "rave parties": ketamine and prolintane].
Gaulier JM; Canal M; Pradeille JL; Marquet P; Lachâtre G
Acta Clin Belg; 2002; 57 Suppl 1():41-6. PubMed ID: 11974443
[TBL] [Abstract][Full Text] [Related]
18. Ketamine : from medicine to misuse.
Wolff K; Winstock AR
CNS Drugs; 2006; 20(3):199-218. PubMed ID: 16529526
[TBL] [Abstract][Full Text] [Related]
19. A brief overview of the clinical pharmacology of "club drugs".
Britt GC; McCance-Katz EF
Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
[TBL] [Abstract][Full Text] [Related]
20. [Dissociative anesthesia, with special reference to psychological disorders caused by ketamine].
Poletto TA
Ann Osp Maria Vittoria Torino; 1974; 17(1-6):122-30. PubMed ID: 4466408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
